Added to YB: 2024-06-19
Pitch date: 2024-06-18
HIMS [bullish]
Hims & Hers Health, Inc.
+51.88%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally.
Market Cap
$8.9B
Pitch Price
$24.50
Price Target
56.00 (+50%)
Dividend
N/A
EV/EBITDA
52.94
P/E
73.02
EV/Sales
4.26
Sector
Health Care Providers and Services
Category
value
Hims & Hers: The Undervalued Gem Poised For Growth
HIMS: Online healthcare platform. Q1 subs +41% YoY to 1.7M, rev +46% to $278M. Adding personalized products driving retention. GLP-1 alternative to Ozempic/Wegovy at <$199/mo amid shortages & rising obesity. PT $56 on 25x P/E of $650M 2028e net income (20% margin on $3.2B rev), 187% upside. Risks: GLP-1 availability, CEO controversy.
Read full article (5 min)